Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Molecular Biology LH-RH-Peptides-as-contraceptives

 Filter arrangement
It is an object of the present invention to develop a filter arrangement of the type mentioned at ...


 Vapor cleaning system
OF THE INVENTION When references are made to the accompanying drawing, the similar characters of ...


 Microbial degradation of obnoxious organic wastes into innocucous materials
We claim: 1. A biologically pure culture of Pseudomonas cepacia var., niagarous selected from the ...


 Process of the pulping of bleaching of vegetable material
A principal object of the present invention is to provide a process for producing pulp which ...


 Method of preparing galcatooligosaccharide
OF THE INVENTION According to the present invention, .beta.-galactosidase having a galactosyl ...


 Process for the two-stage decomposition of hemi-celluloses to xylose
What is claimed is: 1. In a process for the two-stage decomposition of a hemi-cellulose of a xylan-...


 No dig seepage pit cleaner
What is claimed is: 1. A seepage pit cleaner comprising a fluid conduit and a cleaning assembly, ...


 Organosolv delignification and saccharification process for lignocellulosic plant materials
We claim: 1. In a process for the production of carbohydrate hydrolysates of cellulose from a ...


 Tartrate catabolism gene
What is claimed is: 1. A method for making an incompetent unicellular microorganism host competent ...


 Method of encapsulating cells in a tubular extrudate
Methods and systems are disclosed for encapsulating viable cells which produce biologically-active ...


 LH-RH-Peptides as contraceptives

Details
Inventors: von der Ohe, Marianne; Sandow, Jurgen K.; von Rechenberg, Wolfrad;
Assignee: Hoechst Aktiengesellschaft (Frankfurt am Main, DE)
Primary Examiner: Waddell; Frederick E.
Assistant Examiner:
Attorney, Agent or Firm: Curtis, Morris & Safford

What is disclosed in a method of inducing a contraceptive effect in a mammal by administering a contraceptively effective amount of a peptide of the formula ##STR1## in which X stands for D-serine-tert.butyl ether or D-glutamic acid .gamma.-cyclohexylamide.

DETAILED DESCRIPTION What is claimed is: 1.
The method of inducing a contraceptive effect in a male of female patient which comprises parenterally administering to said patient, over a period of at least four days, a daily dose from 0.
05 to 1.
0 micrograms per kilogram of body weight of a peptide of the formula Glu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-NHC.
sub.
2 H.
sub.
5 wherein X is D-serine-tert.
butyl ether or D-glutamic acid .
delta.
-cyclohexyl amide.
2.
The method of inducing a contraceptive effect in a male or female patient which comprises intranasally administering to said patient, over a period of at least four days, a daily dose from 2 to 40 micrograms per kilogram of body weight of a peptide of the formula Glu-His-Trp-Ser-Tyr-X-Leu-Arg-Pro-NHC.
sub.
2 H.
sub.
5, wherein X is D-serine-tert.
butyl ether or D-glutamic acid .
delta.
-cyclohexyl amide.




Description:
This invention relates to the use of peptides of the formula ##STR2## in which X denotes D-serine-tert.
butyl ether or D-glutamic acid .
gamma.
-cyclohexylamide as contraceptives.
The aforementioned compounds are prepared by the processes disclosed in U.
S.
Pat.
No.
4,024,248 and U.
S.
Pat.
No.
4,118,483.
In test persons a single dose of 1.
4 to 20 mcg (corresponding to 20 to 300 ng/kg) administered intravenously (i.
v.
), subcutaneously (s.
c.
) or by the intramuscular route (i.
m.
) or of 50 to 1,000 mcg (corresponding to 100 to 5,000 ng/kg) administered intranasally (i.
n.
) causes the secretion of gonadotrophic hormones from the anterior lobe of the pituitary gland.
It has now been found that repeated doses of more than 2.
5 mcg i.
v.
, s.
c.
or i.
m.
(daily dose) or over about 100 mcg i.
n.
over a period of at least 4 days do not increase the effect but, surprisingly, that the effect is reversed so that the aforesaid compounds can be used as contraceptives when administered in appropriate doses to male and female mammals.
The mechanism of this effect may be explained as follows: The compounds administered have a strong effect on the release of gonadotrophins from the pituitary gland and also stimulate the synthesis of these hormones



Related patents
  Long lasting agonists and antagonists of LH-RH
What is claimed is: 1. A novel peptide of the formula: ##STR15## wherein for A the L- or D- N-acetyl or N-pyroGlu imino acid is a member selected from the group ...
  Synthetic pyridyl-alanyl decapeptides having antiovulatory activity
What is claimed: 1. [N-Ac-D-2-Nal .sup.1,pCl-D-Phe.sup.2,D-3-Pal.sup.3,D-Arg.sup.6,D-Ala.sup.10 ]-LHRH. 2. Analogs of LHRH wherein position 1 is N-Ac-pCl-D-Phe, N-Ac-D-2-...
  Combination therapy for treatment of female breast cancer
OF THE INVENTION In one preferred aspect, the present invention provides an effective method of treating breast cancer in warm-blooded female animals in need of such ...
  Method of depositing electrostatically charged liquid coating material
What we claim is: 1. In a method of depositing liquid coating material on an article in a system in which coating material particles are formed from a thin stream of a ...
  Mechanically viable developer materials
What is claimed is: 1. A carrier particle for electrostatographic developer mixtures, said carrier particle having an average particle diameter from between about 30 ...
  Lithographic type diffusion transfer developing composition
It is, therefore, one object of the present invention to prepare a half-tone dot photographic original plate by the process of diffusion transfer development. Another ...
  Polyiods benzene derivatives and X-ray contrast media containing the same
Having now described our invention what we claim as new and desire to secure by Letters Patent is: 1. A compound selected from a compound of the formula: ##STR17## in ...
  Process for preparing 9.alpha.-OH BN alcohol
OF THE INVENTION The microorganisms which can be used to produce the compounds of the subject invention are the same as disclosed in U.S. Pat. No. 4,029,549. The ...
  [21-leucine] human urogastrone, corresponding gene, corresponding recombinant plasmid, transformed cell and process for production thereof
The present invention is based on the confirmed findings: that a structural gene representing an hUG derivative in which the 21st amino acid residue comprises Leu which ...
  Self-deploying boom
The oil monitoring and pollutant control apparatus comprises a flexible elongated body or boom being so folded that it can be retained in a body of water by a holding ...

0.034

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved